Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons

Journal of the American Heart Association
Marie SahlbergCharlotte Andersson

Abstract

Data from observational studies have raised concerns about the safety of treatment with antipsychotic agents (APs) in elderly patients with dementia, but this area has been insufficiently investigated. We performed a head-to-head comparison of the risk of major adverse cardiovascular events and noncardiovascular mortality associated with individual APs (ziprasidone, olanzapine, risperidone, quetiapine, levomepromazine, chlorprothixen, flupentixol, and haloperidol) in Danish treatment-naïve patients aged ≥70 years. We followed all treatment-naïve Danish citizens aged ≥70 years that initiated treatment with APs for the first time between 1997 and 2011 (n=91 774, mean age 82±7 years, 35 474 [39%] were men). Incidence rate ratios associated with use of different APs were assessed by multivariable time-dependent Poisson regression models. For the first 30 days of treatment, compared with risperidone, incidence rate ratios of major adverse cardiovascular events were higher with use of levomepromazine (3.80, 95% CI 3.43 to 4.21) and haloperidol (1.85, 95% CI 1.67 to 2.05) and lower for treatment with flupentixol (0.54, 95% CI 0.45 to 0.66), ziprasidone (0.31, 95% CI 0.10 to 0.97), chlorprothixen (0.76, 95% CI 0.61 to 0.95), and quetia...Continue Reading

References

Jul 12, 2002·Drugs·Peter M Haddad, Ian M Anderson
Nov 25, 2003·The Journal of Clinical Psychiatry·Rosa LiperotiRoberto Bernabei
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Jan 26, 2005·BMJ : British Medical Journal·Sudeep S GillMuhammad Mamdani
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Feb 28, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sebastian SchneeweissPhilip S Wang
May 5, 2007·Neuroepidemiology·Lars-Henrik KrarupThomas Truelsen
Jun 6, 2007·Annals of Internal Medicine·Sudeep S GillPaula A Rochon
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dilip V JesteKristine Yaffe
Apr 10, 2008·Pharmacoepidemiology and Drug Safety·Hugo LövheimYngve Gustafson
Aug 12, 2008·Journal of the American Geriatrics Society·Soko SetoguchiSebastian Schneeweiss
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Elmira ValiyevaGeoffrey M Anderson
Jan 16, 2009·The New England Journal of Medicine·Wayne A RayC Michael Stein
May 22, 2010·Journal of the American Geriatrics Society·Rebecca C RossomMaurice W Dysken
May 14, 2011·The American Journal of Geriatric Pharmacotherapy·Sandhya MehtaRajender R Aparasu
Oct 29, 2011·Stroke; a Journal of Cerebral Circulation·Shirley WangMalcolm Maclure
Mar 28, 2012·Archives of Internal Medicine·Antoine ParienteYola Moride
Jan 12, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Martin PrinceCleusa P Ferri
Nov 11, 2014·Journal of Multidisciplinary Healthcare·Matisyahu ShulmanAleksey Tentler

❮ Previous
Next ❯

Citations

Feb 26, 2016·Expert Review of Neurotherapeutics·Stefan Hermanowicz, Neal Hermanowicz
Aug 1, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Niklas SchmedtTania Schink
Mar 10, 2016·Journal of Clinical Pharmacology·H Karl Greenblatt, David J Greenblatt
Jan 13, 2017·Current Opinion in Psychiatry·Orestes V ForlenzaFlorindo Stella
Jun 15, 2017·Journal of Psychopharmacology·Kai-Lin HuangRobert Stewart
Feb 13, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Raya Elfadel KheirbekMaria Llorente
May 15, 2018·The Nurse Practitioner·Sushila Pathak, Elsie Duff
Sep 12, 2018·Therapeutic Innovation & Regulatory Science·Donatas StakišaitisRimas Jonas Jankūnas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here